Information on the disease and treatments, assistance with insurance, and transportation are among the types of support ...

In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently ...

The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...

Rachel Dalthorp, MD, discusses how zuranolone (Zurzuvae) can improve postpartum depression when compared with previous ...

This interview accompanies the third podcast in our National Recovery Month series with Kim MacDonald-Wilson, ScD, CPRP, ...

Joseph Alvarnas, MD, of City of Hope, recaps yesterday's Institute for Value-Based Medicine® (IVBM) event on value-based oncology care, emphasizing patient-centered approaches and how attendees can ...

Anant Madabhushi, PhD, executive director for the Emory Empathetic AI for Health Institute, discusses the potential of ...

Physicians in the US, Germany, and France show gaps in their knowledge of the treatment of of refractory/relapsed chronic ...

More than 25 million people lost their Medicaid coverage during the unwinding process conducted by all states after the ...

September 9th 2024EP. 1: The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity A panel of experts examines the impact of cardiometabolic diseases in the United States, focusing on ...

Dr JT Lew Explores the Barriers to MS Medication Access ...